ALSP, Inc. logo — Pioneering small molecule therapies for neurodegenerative di...

ALSP, Inc.

Pioneering small molecule therapies for neurodegenerative diseases, focusing on innovative solutions for traumatic brain injury and Alzheimer's disease.

Founded 2002 United States La Jolla, United States 2 employees Debt Financing Total: $1.15M Biotechnology, Health Care +1

General Information

Company Name ALSP, Inc.
Founded Year 2002
Location United States La Jolla, United States
Employees 2
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with ALSP, Inc.. To contact ALSP, Inc., visit alspinc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About ALSP, Inc.

ALSP, Inc. is a biotechnology company based in San Diego, California, dedicated to pioneering small molecule therapies for neurodegenerative diseases, with a particular focus on traumatic brain injury (TBI) and Alzheimer's disease (AD). The company's approach involves targeting neuroproteases in the brain to inhibit the production of harmful peptides associated with these conditions. Founded in 2002, ALSP has attracted $1.15M in debt financing investment. ALSP's innovative solutions in the treatment of neurodegenerative diseases, particularly TBI and AD, position the company as a promising player in the biotechnology, health care, and pharmaceutical sectors.

Taxonomy: Small molecule therapies, Neurodegenerative diseases, Traumatic brain injury, Alzheimer's disease, Drug development, Enzyme inhibition, Neuroproteases, Biologically active peptides, Compound screening, San Diego, California, Biomedical research, Innovative drug development, Privately held company, Brain health, Pharmaceutical research

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $1.15M -
23 May 2016

ALSP, Inc. Alternatives & Competitors

ALSP, Inc. vs

Advancing Therapeutics and Diagnostics for Amyloid Diseases Since 1996

Venture round
2-10 employees
Biotechnology, Health Care
ALSP, Inc. vs

Therapeutic Solutions for Neurodegeneration

Grant
12 employees
Biotechnology, Pharmaceutical
ALSP, Inc. vs
Senexis Limited
Senexis Limited United Kingdom

Small-molecule therapies targeting amyloid protein toxicity

3 employees
Biotechnology, Life Sciences

FAQ About ALSP, Inc.

Pioneering small molecule therapies for neurodegenerative diseases, focusing on innovative solutions for traumatic brain injury and Alzheimer's disease.
ALSP, Inc. was founded in 2002.
ALSP, Inc. is headquartered in La Jolla, United States.
ALSP, Inc. operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Small molecule therapies, Neurodegenerative diseases, Traumatic brain injury and Alzheimer's disease.
ALSP, Inc. has approximately 2 employees.
ALSP, Inc. has completed 1 funding round, raising a total of $1.15M. The latest funding stage is Debt Financing.
Top alternatives and competitors to ALSP, Inc. include ProteoTech, Alzprotect SAS, Senexis Limited, RH Nanopharmaceuticals , Chase Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ALSP, Inc. and ProteoTech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ALSP, Inc., https://bouncewatch.com/company/alsp-inc, updated 14 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes